ECT2L and liver cancer: Additionally, we also analyzed the expression level of ECT2-L in various large scale studies from TCGA, and found ECT2-L is evidently elevated in multiple cancers, including lung, breast, colon, renal, esophageal, liver cancer, and so on (Fig. 6d and Supplementary Fig. 4a–d).